Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis

Table 1

Selected clinical, biochemical, and echocardiographic characteristics of the patients at baseline.

Age, years	64 (52–82)
Females	4 (31%)
Ischemic cardiomyopathy	8 (61%)
NYHA class III/IV	4/9
Diabetes mellitus	8 (62%)
History of hypertension	8 (62%)
Primary kidney disease	8 (62%)
Body weight, kg	83 (60–107.9)
Mean arterial blood pressure, mm Hg	85.3 (67–108.7)
LVEF, %	20 (7–60)
Preserved LV function	4 (31%)
RV dysfunction	8 (62%)
Estimated SPAP, mm Hg	56 (38–92)
CHF day care treatment	8 (62%)
Medications
Loop diuretic	13 (100%)
Thiazide and thiazide-like diuretics, metolazone	4 (31%)
Spironolactone	4 (31%)
Beta-blockers	12 (92%)
Digoxin	6 (46%)
ACEI or ARB	5 (39%)

Values are expressed as median and range for continuous variables and as absolute numbers and percentages for categorical variables.